# Protalix BioTherapeutics, Inc.: Form 8-K, filed Nov 15, 2021

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 8-K
- Filed: 2021-11-15
- Accepted by EDGAR: Nov 15, 2021, 07:06 ET
- Period: 2021-11-15
- Accession: 0001558370-21-015857
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000155837021015857/plx-20211115x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000155837021015857/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000155837021015857/plx-20211115x8k.htm

Filed Nov 15, 2021.
Source: SEC EDGAR, the filing index for accession 0001558370-21-015857. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
